Certain Nasal Bacteria May Boost COVID-19 Risk
Nasal bacteria can affect the levels of key proteins the SARS-CoV-2 virus needs to enter human cells and may explain why some individuals are more susceptible to COVID-19 infection.
Category: Coronavirus
Coronavirus
Latest
Certain Nasal Bacteria May Boost COVID-19 Risk
Nasal bacteria can affect the levels of key proteins the SARS-CoV-2 virus needs to enter human cells and may explain why some individuals are more susceptible to COVID-19 infection.
Read More
National Investment in COVID-19 Vaccine Had Positive ROI
The United States prevented far more in medical spending and lost-productivity than it spent on testing, buying and delivering the COVID-19 vaccines.
Read More
CDC: ‘The Decision to Vaccinate Is a Personal One’
A recent CDC statement may signal a shift in the agency’s longstanding practice of advocating vaccinations for infectious diseases like measles.
Read More
Novel COVID Antiviral May Overcome Paxlovid Limitations
In laboratory testing, new drug candidate Jun13296 remained effective against Paxlovid-resistant strains of the coronavirus SARS-CoV-2.
Read More
Low-sugar Vaccine Provides Broad Immunity Against Coronavirus Variants
Researchers have developed a universal vaccine that targets coronaviruses and the sugars that they use as cover.
Read More
Canada Creates First-ever Tx Guidelines for Long COVID
The guidelines provide around 100 evidence-based recommendations for preventing and treating long COVID, which affects a reported one million Canadians.
Read More
Five Years Since WHO Declared COVID-19 a Global Pandemic
Five years ago, on March 11, 2020, the World Health Organization declared the coronavirus SARS-CoV-2 a global pandemic.
Read More
Inhaled COVID Vaccine Begins Recruitment for Phase 2 Trial
The phase 2 The AeroVax study will evaluate the safety and effectiveness of a novel inhaled COVID-19 vaccine.
Read More
FDA Clears Visby Medical Flu + COVID Test
Visby Medical’s handheld PCR test that differentiates between influenza A, B, and COVID-19 received FDA clearance and a CLIA waiver.
Read More
Researchers Question Paxlovid’s Impact on COVID-19 Outcomes
Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to UCLA-led research.
Read More
Cases of ME/CFS Increase Following COVID-19
COVID-19 infection may be associated with an increase in the number of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases.
Read More
Nasal COVID-19 Vaccine to Enter Clinical Trials
The FDA approved an investigational new drug application from Ocugen Inc for a nasal COVID-19 vaccine that will begin a Phase 1 clinical trial.
Read More
Link Between Long COVID and Eye Health
Retinal imaging could offer new perspectives on long COVID’s impact.
Read More
New Approach for Antiviral Development
A new antiviral modeling approach combines various experimental techniques to create a comprehensive picture of a virus’ dynamic behavior.
Read More
Post-COVID Inflammation Fuels Coronary Artery Plaque Growth
SARS-CoV-2 infection was associated with the rapid growth of plaque in the coronary arteries and an increased risk of cardiovascular events.
Read More
Molecular ‘Fingerprint’ of Long COVID Found in Children’s Blood
Artificial intelligence identified a molecular signature of long COVID in children’s blood with 93% accuracy, according to a recent study.
Read More
Repeat COVID Infections Behind Most Long COVID Cases, Four-Year Study Finds
Individuals who have had multiple COVID-19 infections appear prone to contracting long COVID, which may include symptoms such as fatigue, respiratory distress, and mental fog.
Read More
COVID-19 May Trigger Separate Chronic Condition Beyond Long COVID
New research suggests COVID-19 infection may lead to cases of a chronic condition, resembling but diagnostically separate from long COVID, characterized by persistent fatigue and post-exertional malaise.
Read More
Paxlovid May Help Some with Long-COVID After All
An up-close look at how patients respond to the drug at different times and doses adds nuance to a recent finding that Paxlovid does not work for long-COVID.
Read More
COVID-19 Infection Not Tied to Worsening MS Symptoms
While infections are often linked to increased disability in people with MS, a new study shows that COVID-19 does not worsen symptoms or disability.
Read More
N95 Masks Can Reduce COVID-19 Transmission Risk by Ninefold: Study
High-quality face masks, such as N95/FFP2, can lower the risk of COVID-19 transmission by up to nine times when used by the entire UK population and by three times with individual use, according to a new study.
Read More
Higher Anticoagulant Doses Reduce Mortality in Hospitalized COVID-19 Patients
A therapeutic dose of anticoagulation with herapins also reduced the need for mechanical ventilation and the risk of thromboembolic events.
Read More
Long COVID’s Toll Extends Beyond Health Impacts
New findings suggest long COVID exacerbates financial instability for Americans, with low-income groups bearing the brunt.
Read More
Wearable TENS Device Eases Long COVID Symptoms
The transcutaneous electrical nerve stimulation device “offered immediate, on-demand relief,” say researchers.
Read More